STUDIES ON THE HYPERGLYCAEMIA INDUCED BY CHLORPROMAZINE IN RATS.
Chlorpromazine induces in rats a marked and long-lasting hyperglycaemia which (a) is more marked at low than high room temperatures, (b) is inhibited by phentolamine but not by dibenamine, and (c) is prevented by adrenalectomy, by removal of the adrenal medullae and by treatment of the rats with reserpine. Other experimental results suggest that there is a correlation between the hyperglycaemia and the hypothermia induced by chlorpromazine and by its congeners. The hyperglycaemia seems to be the result of at least two factors: an activation of the adrenergic mechanisms and an impaired peripheral utilization of glucose.
D000313:Adrenal Medulla; D000315:Adrenalectomy; D002746:Chlorpromazine / Q000633:toxicity*; D003983:Dibenzylchlorethamine; D005947:Glucose / Q000378:metabolism*; D006943:Hyperglycemia; D007267:Injections; D007274:Injections, Intraperitoneal; D010600:Pharmacology; D010646:Phentolamine; D051381:Rats; D012106:Research; D012110:Reserpine; D013565:Sympatholytics; D013696:Temperature; D013881:Thioridazine; D014273:Triflupromazine
D013565:Sympatholytics; D003983:Dibenzylchlorethamine; D012110:Reserpine; D005947:Glucose; D013881:Thioridazine; D014273:Triflupromazine; D002746:Chlorpromazine; D010646:Phentolamine
ADRENAL MEDULLA; ADRENALECTOMY; CHLORPROMAZINE TOXICOLOGY; DIBENAMINE; EXPERIMENTAL LAB STUDY; GLUCOSE METABOLISM; HYPERGLYCEMIA; INJECTIONS, INTRAPERITONEAL; PHARMACOLOGY; PHENTOLAMINE; RATS; RESERPINE; SYMPATHOLYTICS; TEMPERATURE; THIORIDAZINE; TRIFLUPROMAZINE